Skip to content

Neuroprotective effect of taurine

An experimental animal model of Huntington’s disease (HD) phenotype was induced with the mycotoxin 3-nitropropionic acid (3-NP) and was well characterized behaviorally, neurochemically, morphometrically, and histologically. Administration of 3-NP caused a decrease in prepulse inhibition (PPI) of the acoustic startle response, locomotor hyperactivity and/or hypoactivity, bilateral striatal lesions, brain oxidative stress, and decreased striatal gamma-aminobutyric acid (GABA) levels.

Taurine is a semi-essential beta-amino acid that has been shown to have both antioxidant and GABA-A agonistic activity. In this study, treatment with taurine (200 mg/kg daily for 3 days) before 3-NP administration reversed both the reduced PPI response and the locomotor underactivity caused by 3-NP injection.

Taurine pretreatment also caused an approximately 2-fold increase in GABA concentration compared with 3-NP-treated animals. In addition, taurine showed antioxidant activity against oxidative stress induced by 3-NP administration, as evidenced by reduced levels of striatal malondialdehyde (MDA) and increased levels of striatal glutathione (GSH). Histochemical examination of striatal tissue showed that prior administration of taurine before 3-NP challenge significantly increased succinate dehydrogenase (SDH) activity compared with 3-NP-treated animals. Histopathological examination further confirmed the neuroprotective effect of taurine in 3-NP-induced HD in rats.

In conclusion, taurine plays a neuroprotective role in the current HD paradigm, which is at least partly due to its indirect antioxidant effect and the agonistic effect of GABA.

Pharmacol Biochem Behav.: Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington’s disease phenotype

Found at Alkohol adé (german)

Powered by BetterDocs

Close Popup

Bye bye booze needs a few cookies, too.

However, we try only to activate as few as possible technically necessary cookies so that your visit to this site cannot be tracked as far as possible by third parties. We do not share any information about your visit with anyone.

But even we we do need a few - e.g. to display this legal notice or to care for that you do not have to log in again for each page or see this popup again for each page.

As soon as you click on an external link or video, cookies may be set by the operators of these sites, which we cannot influence. Learn more on our privacy page.

Close Popup